All visitors must be escorted in areas 

other than the lower and first floor 

levels in the Central Building. 

Authority: Sec. 1114(f) of the Social 

Security Act (42 U.S.C. 1314(f)), sec. 222 of 

the Public Health Service Act (42 U.S.C. 

217a), and sec. 10(a) of Pub. L. 92–463 (5 

U.S.C. App. 2, sec. 10(a) and 41 CFR 102–3). 

Dated: February 16, 2017. 

Patrick Conway, 

Acting Administrator Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2017–03598 Filed 2–23–17; 8:45 am] 

BILLING CODE 4120–01–P 


asabaliauskas on DSK3SPTVN1PROD with NOTICES

Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices 11585 

The current members of the Panel are: 

Kellan Baker, Associate Director, Center 

for American Progress; Robert Blancato, 

President, Matz, Blancato & Associates; 

Dale Blasier, Professor of Orthopaedic 

Surgery, Department of Orthopaedics, 

Arkansas Children’s Hospital; Deborah 

Britt, Executive Director of Community 

& Public Relations, Piedmont Fayette 

Hospital; Deena Chisolm, Associate 

Professor of Pediatrics & Public Health, 

The Ohio State University, Nationwide 

Children’s Hospital; Josephine DeLeon, 

Director, Anti-Poverty Initiatives, 

Catholic Charities of California; Robert 

Espinoza, Vice President of Policy, 

Paraprofessional Healthcare Institute; 

Louise Scherer Knight, Director, The 

Sidney Kimmel Comprehensive Cancer 

Center at Johns Hopkins; Roanne 

Osborne-Gaskin, M.D., Senior Medical 

Director, MDWise, Inc.; Cathy Phan, 

Outreach and Education Coordinator, 

Asian American Health Coalition DBA 

HOPE Clinic; Kamilah Pickett, 

Litigation Support, Independent 

Contractor; Brendan Riley, Outreach 

and Enrollment Coordinator, NC 

Community Health Center Association; 

Alvia Siddiqi, Medicaid Managed Care 

Community Network (MCCN) Medical 

Director, Advocate Physician Partners, 

Carla Smith, Executive Vice President, 

Healthcare Information and 

Management Systems Society (HIMSS); 

Tobin Van Ostern, Vice President and 

Co-Founder, Young Invincibles 

Advisors; and Paula Villescaz, Senior 

Consultant, Assembly Health 

Committee, California State Legislature. 

II. Provisions of This Notice 

In accordance with section 10(a) of 

the FACA, this notice announces a 

meeting of the APOE. The agenda for 

the March 22, 2017 meeting will include 

the following: 

•	 Welcome and listening session with 

CMS leadership 

•	 Recap of the previous (September 21, 

2016) meeting 

•	 Affordable Care Act initiatives 

•	 An opportunity for public comment 

•	 Meeting summary, review of 

recommendations, and next steps 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES 

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make an oral 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES 

section of this notice. 

III. Security, Building, and Parking 

Guidelines 

This meeting will be held in a federal 

government building; therefore, federal 

security measures are applicable. The 

Real ID Act, enacted in 2005, establishes 

minimum standards for the issuance of 

state-issued driver’s licenses and 

identification (ID) cards. It prohibits 

federal agencies from accepting an 

official driver’s license or ID card from 

a state unless the Department of 

Homeland Security determines that the 

state meets these standards. Beginning 

October 2015, photo IDs (such as a valid 

driver’s license) issued by a state or 

territory not in compliance with the 

Real ID Act will not be accepted as 

identification to enter federal buildings. 

Visitors from these states/territories will 

need to provide alternative proof of 

identification (such as a valid passport) 

to gain entrance into CMS buildings. 

The current list of states from which a 

federal agency may accept driver’s 

licenses for an official purpose is found 

at http://www.dhs.gov/real-idenforcement-brief. We recommend that 

confirmed registrants arrive reasonably 

early, but no earlier than 45 minutes 

prior to the start of the meeting, to allow 

additional time to clear security. 

Security measures include the 

following: 

• Presentation of government issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means, of all persons 

entering the building. We note that all 

items brought into CMS, whether 

personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Final Effect of Designation of a Class 

of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice concerning 

the final effect of the HHS decision to 

designate a class of employees from the 

Pantex Plant in Amarillo, Texas, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS 

C–46, Cincinnati, OH 45226–1938, 

Telephone 877–222–7570. Information 

requests can also be submitted by email 

to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

7384l(14)(C). 

On January 4, 2017, as provided for 

under 42 U.S.C. 7384l(14)(C), the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and their 

contractors and subcontractors who worked 

at the Pantex Plant in Amarillo, Texas, 

during the period from January 1, 1951, 

through December 31, 1957, for a number of 

work days aggregating at least 250 work days, 

occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort. 

This designation became effective on 

February 3, 2017. Therefore, beginning 
DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

Santa Susana Field Laboratory in 

Eastern Ventura County, California, To 

Be Included in the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice of a 

decision to evaluate a petition to 

designate a class of employees from 

Area IV of the Santa Susana Field 

Laboratory in eastern Ventura County, 

California, to be included in the Special 

Exposure Cohort under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 1090 Tusculum 

Avenue, MS C–46, Cincinnati, OH 

F

o

A

(

a

a

A

S

t

d

L

E

E

F

S

o

r

t

S

7


asabaliauskas on DSK3SPTVN1PROD with NOTICES

11586 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices 

on February 3, 2017, members of this 

class of employees, defined as reported 

in this notice, became members of the 

SEC. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2017–03676 Filed 2–23–17; 8:45 am] 

BILLING CODE 4163–19–P 

45226–1938, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 CFR 83.9–83.12. 

Pursuant to 42 CFR 83.12, the initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Area IV of the Santa Susana 

Field Laboratory. 

Location: Eastern Ventura County, 

California. 

Job Titles and/or Job Duties: All 

employees of North American Aviation, 

including corporate successors and 

subcontractors, who worked at site Area 

IV of the Santa Susana Field Laboratory 

(SSFL). 

Period of Employment: August 1, 

1991 through June 30, 1993. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2017–03674 Filed 2–23–17; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

inal Effect of Designation of a Class 

f Employees for Addition to the 

Special Exposure Cohort 

GENCY: National Institute for 

Occupational Safety and Health 

NIOSH), Centers for Disease Control 

nd Prevention, Department of Health 

nd Human Services (HHS). 

CTION: Notice. 

UMMARY: HHS gives notice concerning 

he final effect of the HHS decision to 

esignate a class of employees from 

Area IV of the Santa Susana Field 

aboratory in Ventura County, 

California, as an addition to the Special 

xposure Cohort (SEC) under the Energy 

mployees Occupational Illness 

Compensation Program Act of 2000. 

OR FURTHER INFORMATION CONTACT: 

tuart L. Hinnefeld, Director, Division 

f Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS 

C–46, Cincinnati, OH 45226–1938, 

Telephone 877–222–7570. Information 

equests can also be submitted by email 

o DCAS@CDC.GOV.

UPPLEMENTARY INFORMATION: 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

384l(14)(C). 

On January 6, 2017, as provided for 

under 42 U.S.C. 7384l(14)(C), the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and their 

contractors and subcontractors who worked 

in any area at Area IV of the Santa Susana 

Field Laboratory in Ventura County, 

California, from January 1, 1965, through 

December 31, 1988, for a number of work 

days aggregating at least 250 work days, 

occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees 

included in the Special Exposure Cohort. 

This designation became effective on 

February 5, 2017. Therefore, beginning 

on February 5, 2017, members of this 

class of employees, defined as reported 

in this notice, became members of the 

SEC. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2017–03675 Filed 2–23–17; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Acquired Immunodeficiency 

Syndrome Research Review Committee. 

Date: March 22–23, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Arlington Capital View 

Hotel, Studio F, 2800 S. Potomac Avenue, 

Arlington, VA 22202. 

Contact Person: Peter R. Jackson, Ph.D., 

Chief, AIDS Research Review Branch, 

Scientific Review Program, Division of 

Extramural Activities, Room #3G20, National 

Institutes of Health/NIAID, 5601 Fishers 

Lane, MSC 9834, Bethesda, MD 20892–9834, 

(240) 669–5049, pjackson@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 21, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–03692 Filed 2–23–17; 8:45 am] 

BILLING CODE 4140–01–P